ESR1 and cancer: In this regard, it has been reported that E2 regulates the activity of EZH2 through non-genomic signaling mediated by ERα and ERβ leads, which leads to phosphorylation of EZH2 by AKT and MAPK pathways in benign and cancer prostate cells (36).